<DOC>
	<DOCNO>NCT03045367</DOCNO>
	<brief_summary>This study evaluate safety efficacy simultaneous , trans-conjunctival , 25-Gauge vitrectomy phacoemulsification intraocular lens implant patient metamorphopsia visual impairment due idiopathic epiretinal membrane cataract . All 30 patient recruited underwent complete ocular examination , visual acuity measurement ETDRS , metamorphopsia assessment M-Charts Metamorphometry® foveal thickness evaluation sd-OCT preoperatively , 30 , 90 , 180 day postoperatively .</brief_summary>
	<brief_title>Mid-term Evaluation Metamorphopsia Epiretinal Membrane Surgery</brief_title>
	<detailed_description />
	<mesh_term>Cataract</mesh_term>
	<mesh_term>Epiretinal Membrane</mesh_term>
	<mesh_term>Vision Disorders</mesh_term>
	<criteria>age &gt; 55 year visual acuity ≤ 20/40 idiopathic epiretinal membrane cataract Amsler test positive metamorphopsia . previous ocular intervention ocular disease .</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Metamorphopsia</keyword>
	<keyword>Epiretinal membrane</keyword>
	<keyword>Vitrectomy</keyword>
</DOC>